Mixing two different COVID-19 vaccines gives a better immune response?


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴ Mixing two different COVID-19 vaccines gives a better immune response?
Different studies are being carried out worldwide to understand if a combination of two different vaccines can outperform two doses of the same vaccines

The DGCI has given permission to conduct a trial study of mixed doses of Covaxin and Covishield. The study will get conducted by Christian Medical College (CMC) Vellore and will include 300 trial participants. The two vaccine uses different platforms: Covishield is an adenovirus vector platform-based vaccine, while Covaxin is an inactivated whole virus vaccine.

Earlier this year, in May, 18 villagers of district Siddharth Nagar, Uttar Pradesh had got Covishield as the first vaccine dose and Covaxin as the second dose mistakenly. This was not done purposely. The study compares the vaccine response of these 18 villagers with 40 recipients of two doses of Covishield and 40 recipients of two doses of Covaxin. The study illustrates that a combination of (heterologous) different vaccines shows a better immune response than the two doses of the same (homologous) vaccine. 

According to the World Health Organization, there is currently limited data on the immunogenicity or efficacy of a “mix and match” regimen. WHO said, “mix-and-match regimens are likely to work. However, we need to analyze the evidence in each of these vaccine combinations before any other recommendations can be made.”

Before Covid-19, studies have shown better and broader immune responses with the mixing of vaccines of different types. Such heterologous strategies are being studied in HIV, malaria, flavivirus (e.g. dengue), HPV, Ebola, and influenza. 

The idea of heterologous boosting initially emerged in Europe, when the AstraZeneca vaccine was found to be associated with blood clotting in a handful of individuals. A second dose with a different platform vaccine was recommended.

Tags : #Spotlight #Covishield #Covaxin #Mixedvaccination #DGCI #WHO #Latestnewsonvaccine #SmitaKumar #Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026